Back
Mitek Systems, Inc. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Sell
50
MITK
Mitek Systems, Inc.
Last Price:
$9.26
Seasonality Move:
19.16%
Buy
77
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.09
Seasonality Move:
9.28%
Sell
50
Mitek Systems, Inc. (MITK)
is a Sell
Is Mitek Systems, Inc. a Buy, Sell or Hold?
-
The current Mitek Systems, Inc. [MITK] share price is $9.23. The Score for MITK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
MITK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.19. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MITK Stock Price Chart
What is Mitek Systems, Inc.'s stock price today?
-
The Mitek Systems, Inc. share price today is $9.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MITK is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
MITK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 53.41 | Buy |
| Chaikin Money Flow: | -91358 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 22.82 | Buy |
| Relative Strength Index (14 RSI): | 85.91 | Buy |
| Chaikin Money Flow: | 334557 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (142.93 - 241.17) | Buy |
| Bollinger Bands (100): | (50.82 - 164.58) | Buy |
MITK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.18 | Buy |
| 20-day SMA: | 9.01 | Buy |
| 50-day SMA: | 9.21 | Buy |
| 200-day SMA: | 9.32 | Sell |
| 8-day EMA: | 9.15 | Buy |
| 20-day EMA: | 9.11 | Buy |
| 50-day EMA: | 9.25 | Sell |
| 200-day EMA: | 9.51 | Sell |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.24 | Sell |
| 20-day SMA: | 213.95 | Buy |
| 50-day SMA: | 147.6 | Buy |
| 200-day SMA: | 67.86 | Buy |
| 8-day EMA: | 219.1 | Buy |
| 20-day EMA: | 202.41 | Buy |
| 50-day EMA: | 160.57 | Buy |
| 200-day EMA: | 86.75 | Buy |
Mitek Systems, Inc. Earnings Growth & MITK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.18 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
Mitek Systems, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||